News

Dr Dhanashree Peddawad, Consultant- Neurologist, Jupiter Hospital talks about the common misconceptions about autism.

Molnupiravir is one of the two recent oral antiviral pills approved by the USFDA for COVID-19 and the first oral antiviral to…

Dr Alok V. Kulkarni, Mental Wellness Expert and Senior Psychiatrist, Manas Institute of Mental Health talks about women's mental…

Dr Swati Subodh- Co-founder, One Million for One Billion (1M1B) Foundation highlights the various aspects which will be crucial…

Little research has previously been conducted on how vaccines for COVID-19 or vaccines for other diseases could potentially…

The vaccine was estimated to be 91 per cent effective in preventing Multisystem Inflammatory Syndrome in Children (MIS-C) in 12-…

The prevalence of psychological distress in AYA cancer survivors was two times higher than that observed in adults with no history…

The research by the Center of Infection and Immunity of Columbia University of New York confirms that CoviSelf is able to detect…

The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events

Intravacc will focus on a number of additional and preliminary preclinical exercises and the process development research of the…